Targovax to present and attend at upcoming conferences
Oslo, 7 December 2022 – Targovax ASA announces that members of its executive management team are invited to present at following upcoming conferences:7th Annual Oncolytic Virotherapy Summit, Boston, USADate: 7 December 2022Presenter: Erik Digman Wiklund, CEOTime: 12:00 EDT / 18:00 CET DNB Nordic Healthcare Conference, Oslo, NorwayDate: 15 December 2022Presenter: Erik Digman Wiklund, CEOTime: 15:10 CET Biotech Showcase, J.P. Morgan Healthcare weekDate: 9-12 January 2023Attending: Erik Digman Wiklund, CEO, Lubor Gaal, CFO ***